Year |
Citation |
Score |
2018 |
Xu L, Gordon R, Farmer R, Pattanayak A, Binkowski A, Huang X, Avram M, Krishna S, Voll E, Pavese J, Chavez J, Bruce J, Mazar A, Nibbs A, Anderson W, et al. Precision therapeutic targeting of human cancer cell motility. Nature Communications. 9: 2454. PMID 29934502 DOI: 10.1038/S41467-018-04465-5 |
0.728 |
|
2014 |
Pavese JM, Ogden IM, Voll EA, Huang X, Xu L, Jovanovic B, Bergan RC. Mitogen-activated protein kinase kinase 4 (MAP2K4) promotes human prostate cancer metastasis. Plos One. 9: e102289. PMID 25019290 DOI: 10.1371/Journal.Pone.0102289 |
0.784 |
|
2014 |
Pavese JM, Bergan RC. Circulating tumor cells exhibit a biologically aggressive cancer phenotype accompanied by selective resistance to chemotherapy. Cancer Letters. 352: 179-86. PMID 25016063 DOI: 10.1016/J.Canlet.2014.06.012 |
0.739 |
|
2014 |
Pavese JM, Krishna SN, Bergan RC. Genistein inhibits human prostate cancer cell detachment, invasion, and metastasis. The American Journal of Clinical Nutrition. 100: 431S-6S. PMID 24871471 DOI: 10.3945/Ajcn.113.071290 |
0.813 |
|
2014 |
Voll EA, Ogden IM, Pavese JM, Huang X, Xu L, Jovanovic BD, Bergan RC. Heat shock protein 27 regulates human prostate cancer cell motility and metastatic progression. Oncotarget. 5: 2648-63. PMID 24798191 DOI: 10.18632/Oncotarget.1917 |
0.783 |
|
2013 |
Pavese J, Ogden IM, Bergan RC. An orthotopic murine model of human prostate cancer metastasis. Journal of Visualized Experiments : Jove. e50873. PMID 24084571 DOI: 10.3791/50873 |
0.74 |
|
2012 |
Xu L, Farmer R, Huang X, Pruell S, Voll E, Pavese J, Valsecchi M, Biddle M, Nibbs A, Avram M, Scheidt KA, Bergan RC. Abstract 4752: Selective inhibition of cancer metastasis with a novel small therapeutic molecule Cancer Research. 72: 4752-4752. DOI: 10.1158/1538-7445.Am2012-4752 |
0.795 |
|
2012 |
Pavese JM, Ogden I, Huang X, Bergan R. Abstract 3277: Increased mitogen-activated protein kinase kinase 4 (MEK4) induces metastasis in an orthotopic murine model of prostate cancer Cancer Research. 72: 3277-3277. DOI: 10.1158/1538-7445.Am2012-3277 |
0.747 |
|
2011 |
Pavese JM, Ogden IM, Huang X, Xu L, Bergan RC. Abstract 1407: Mitogen-activated protein kinase kinase 4 (MEK4) is a key regulator of prostate cancer progression Cancer Research. 71: 1407-1407. DOI: 10.1158/1538-7445.Am2011-1407 |
0.777 |
|
2011 |
Xu L, Farmer R, Huang X, Valsecchi M, Pavese J, Voll E, Biddle M, Nibbs A, Pruell S, Avram M, Scheidt K, Bergan RC. Abstract C177: Chemical-driven biological probing: Discovery of a novel antimetastatic drug. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-C177 |
0.79 |
|
2010 |
Pavese JM, Farmer RL, Bergan RC. Inhibition of cancer cell invasion and metastasis by genistein. Cancer Metastasis Reviews. 29: 465-82. PMID 20730632 DOI: 10.1007/S10555-010-9238-Z |
0.79 |
|
2010 |
Xu L, Farmer R, huang x, Pavese J, Voll E, Irene O, Biddle M, Nibbs A, Valsecchi M, Scheidt K, Bergan R. Abstract B58: Discovery of a novel drug KBU2046 that inhibits conversion of human prostate cancer to a metastatic phenotype Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-10-B58 |
0.804 |
|
Show low-probability matches. |